| Cell line name |
Mel 23 |
|---|
| Synonyms |
Melanoma-23 |
|---|
| Accession |
CVCL_0D08 |
|---|
| Resource Identification Initiative |
To cite this cell line use: Mel 23 (RRID:CVCL_0D08) |
|---|
| Comments |
Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167. |
|---|
| Disease |
Canine oral melanoma (NCIt: C185639) |
|---|
| Species of origin |
Canis lupus familiaris (Dog) (Canis familiaris)
(NCBI Taxonomy: 9615) |
|---|
| Sex of cell |
Sex unspecified |
|---|
| Age at sampling |
Age unspecified |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=19147538; DOI=10.1158/1541-7786.MCR-08-0347; PMCID=PMC2653090
Jin Zhang, Xiang-Ling Chen, Michael S. Kent, Carlos O. Rodriguez, Xin-Bin Chen;
Establishment of a dog model for the p53 family pathway and identification of a novel isoform of p21 cyclin-dependent kinase inhibitor.
Mol. Cancer Res. 7:67-78(2009) PubMed=19231960; DOI=10.2460/ajvr.70.2.263; PMCID=PMC4169881
Michael S. Kent, Cameron J. Collins, Fang Ye;
Activation of the AKT and mammalian target of rapamycin pathways and the inhibitory effects of rapamycin on those pathways in canine malignant melanoma cell lines.
Am. J. Vet. Res. 70:263-269(2009) CLPUB00732
Megan Nicole Breit;
Biologic activity of the novel SINE compound KPT-335 against canine melanoma cell lines.
Thesis MSc (2014); Ohio State University; Columbus; USA PubMed=25022346; DOI=10.1186/1746-6148-10-160; PMCID=PMC4105800
Megan Nicole Breit, William C. Kisseberth, Misty D. Bear, Yosef Landesman, Trinayan Kashyap, Dilara McCauley, Michael G. Kauffman, Sharon Shacham, Cheryl A. London;
Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell lines.
BMC Vet. Res. 10:160.1-160.11(2014) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54905047
|
|---|
| Entry history |
|---|
| Entry creation | 10-Apr-2015 |
|---|
| Last entry update | 29-Jun-2023 |
|---|
| Version number | 7 |
|---|
